Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced Esophageal Cancers”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT00915850
What this trial is testing

Trial of Docetaxel, Cisplatin, Fluorouracil (5-FU) for Unresectable Advanced Esophageal Squamous Cell Carcinoma (ESCC)

Who this might be right for
Esophageal Cancer
Wakayama Medical University 32
Early research (Phase 1)Active Not RecruitingNCT02213497
What this trial is testing

Dose Escalation of Neoadjuvant Proton Beam Radiotherapy With Concurrent Chemotherapy in Locally Advanced Esophageal Cancer

Who this might be right for
Esophageal Cancer
Abramson Cancer Center at Penn Medicine 30
Large-scale testing (Phase 3)Not Yet RecruitingNCT06952621
What this trial is testing

Neoadjuvant Treatment of Toripalimab Combined With Nab-paclitaxel and Platinum Versus Neoadjuvant Docetaxel Combined With Cisplatin and 5-fluorouracil (DCF) in Esophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal Squamous Cell Carcinoma (ESCC)
Tang-Du Hospital 390
Early research (Phase 1)UnknownNCT00682227
What this trial is testing

Peptide Vaccination in Treating Patients With Esophageal Cancer

Who this might be right for
Esophageal Cancer
University of Yamanashi 10
Not applicableUnknownNCT01630174
What this trial is testing

IMRT/Pemetrexed/Cisplatin in Esophageal Cancer

Who this might be right for
Esophageal Cancer
Shandong Cancer Hospital and Institute 30
Not applicableLooking for participantsNCT07272382
What this trial is testing

Omega-3 Fatty Acids With PD-1 Inhibitors in Advanced Esophageal Cancer

Who this might be right for
Esophageal Neoplasms
Fudan University 142
Testing effectiveness (Phase 2)UnknownNCT05376423
What this trial is testing

To Evaluate OBI-833/OBI-821 in Patients With Locally Advanced, Globo H-Positive Esophageal Cancer for Recurrence

Who this might be right for
Esophageal Cancer
National Taiwan University Hospital 60
Testing effectiveness (Phase 2)UnknownNCT05323890
What this trial is testing

Tislelizumab Combined With Neoadjuvant Radiotherapy and Chemotherapy for Resectable Esophageal Squamous Cell Carcinoma.

Who this might be right for
Advanced Esophageal Squamous Cell Cancer
Shandong Cancer Hospital and Institute 15
Early research (Phase 1)Study completedNCT00004074
What this trial is testing

Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu

Who this might be right for
Advanced Adult Primary Liver CancerAnaplastic Thyroid CancerBone Metastases+124 more
National Cancer Institute (NCI) 15
Early research (Phase 1)Study completedNCT04045496
What this trial is testing

A First-in-Human, Phase 1 Study of JAB-3312 in Adult Patients With Advanced Solid Tumors

Who this might be right for
Non-small Cell Lung CancerColorectal CancerPancreatic Ductal Carcinoma+4 more
Jacobio Pharmaceuticals Co., Ltd. 40
Testing effectiveness (Phase 2)UnknownNCT00553683
What this trial is testing

Cyclophosphamide, Radiation Therapy, and Poly ICLC in Treating Patients With Unresectable, Recurrent, Primary, or Metastatic Liver Cancer

Who this might be right for
Breast CancerColorectal CancerGastric Cancer+5 more
Rutgers, The State University of New Jersey 50
Testing effectiveness (Phase 2)Study completedNCT00030862
What this trial is testing

Combination Chemotherapy in Treating Patients With Locally Advanced or Metastatic Cancer of the Esophagus

Who this might be right for
Esophageal Cancer
Memorial Sloan Kettering Cancer Center
Early research (Phase 1)Study completedNCT01175460
What this trial is testing

S-1 Plus Nedaplatin With Concurrent Radiotherapy for Advanced Esophageal Cancer

Who this might be right for
Esophageal Cancer
Zhejiang Cancer Hospital 15
Not applicableUnknownNCT05426850
What this trial is testing

CtDNA-based MRD Assessment in Local Advanced Esophageal Carcinoma

Who this might be right for
Esophageal Squamous Cell Carcinoma
Fudan University 100
Testing effectiveness (Phase 2)UnknownNCT05469061
What this trial is testing

Tislelizumab in Combination With Chemotherapy for Conversion Therapy of Locally Nonresectable ESCC

Who this might be right for
Esophageal Squamous Cell CarcinomaLocally Advanced Carcinoma
The First Affiliated Hospital with Nanjing Medical University 17
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07623642
What this trial is testing

A Phase II Study of GV20-0251 in Combination With Anti-PD-1 Monoclonal Antibodies in Patients With Unresectable, Locally Advanced, or Metastatic Solid Tumors.

Who this might be right for
Uterine Cervical NeoplasmsTriple Negative Breast NeoplasmsProstatic Neoplasms+8 more
GV20 Therapeutics 227
Early research (Phase 1)Study completedNCT04164069
What this trial is testing

Dasatinib for the Prevention of Oxaliplatin-Induced Neuropathy in Patients With Metastatic Gastrointestinal Cancer Receiving FOLFOX Chemotherapy With or Without Bevacizumab

Who this might be right for
Advanced Colorectal CarcinomaMetastatic Colorectal CarcinomaStage IV Colorectal Cancer AJCC v8+13 more
Anne Noonan 9
Testing effectiveness (Phase 2)Study completedNCT00607594
What this trial is testing

Saracatinib in Treating Patients With Locally Advanced or Metastatic Stomach or Gastroesophageal Junction Cancer

Who this might be right for
Adenocarcinoma of the Gastroesophageal JunctionAdenocarcinoma of the StomachRecurrent Gastric Cancer+4 more
National Cancer Institute (NCI) 21
Not applicableStudy completedNCT01269970
What this trial is testing

Early Metabolic Response in Locally Advanced Esophageal Cancer Undergoing Induction Chemoradiotherapy

Who this might be right for
Esophageal Carcinoma (Squamous Cell Carcinoma - Adenocarcinoma)
Universitaire Ziekenhuizen KU Leuven
Early research (Phase 1)UnknownNCT00010270
What this trial is testing

LMB-9 Immunotoxin in Treating Patients With Advanced Pancreatic, Esophageal, Stomach, Colon, or Rectal Cancer

Who this might be right for
Colorectal CancerEsophageal CancerGastric Cancer+1 more
University Hospital Freiburg 50
Next Page